Literature DB >> 16394617

Analysis of genes dominantly expressed in rat cerebral endothelial cells using suppression subtractive hybridization.

Takahisa Shibata1, Norihiko Misawa, Chikari Takeo, Naokatsu Saeki, Yasushi Saito, Ichiro Tatsuno.   

Abstract

In mammals, a fully developed, highly branched vascular system specialized for each particular organ or tissue is essential for obtaining metabolic nutrients supply. The formation of a blood-brain barrier that protects against environmental insults is a distinguishing feature of the brain's vascular system. Since this is accomplished by cerebral endothelial cells (CECs), we analyzed the genes specifically and/or dominantly expressed in rat CECs using Suppression Subtractive Hybridization (SSH). We found 39 genes specifically and/or dominantly expressed in CECs. 24 genes of known function (thrombospondin-2, vimentin, etc.), 13 genes of known sequence but unknown function including 7 of ESTs (SNERG1, rat GPCR, etc.), and 2 novel genes. The physiological significance of these genes in CECs has been under investigation. SSH is useful for identifying genes regulated in an organ-specific manner in cells such as CECs to obtain clarification of their physiological roles.

Entities:  

Mesh:

Year:  2005        PMID: 16394617     DOI: 10.5551/jat.12.330

Source DB:  PubMed          Journal:  J Atheroscler Thromb        ISSN: 1340-3478            Impact factor:   4.928


  2 in total

1.  Restoring transcription factor HoxA5 expression inhibits the growth of experimental hemangiomas in the brain.

Authors:  Yiqian Zhu; Ileana C Cuevas; Rodney Allanigue Gabriel; Hua Su; Stephen Nishimura; Peng Gao; Alexander Fields; Qi Hao; William L Young; Guo-Yuan Yang; Nancy J Boudreau
Journal:  J Neuropathol Exp Neurol       Date:  2009-06       Impact factor: 3.685

Review 2.  Combinatorial approaches for the identification of brain drug delivery targets.

Authors:  Charles C Stutz; Xiaobin Zhang; Eric V Shusta
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.